Literature DB >> 10874193

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients.

A Giorgio1, L Tarantino, N Farella, O Catalano, B Cusati, A Alaia, E Caturelli.   

Abstract

OBJECTIVE: To evaluate the efficacy and complications of interstitial laser photocoagulation (ILP) under ultrasound (US) guidance as a technique for focal ablation of liver tumors in patients with normal and impaired hepatic function. PATIENTS AND METHODS: A total of 104 patients, 77 with 85 nodules of hepatocellular carcinoma on cirrhosis (29 in Child-Pugh A class, 43 in B e 5 in C class) and 27 patients with hepatic metastases (25 from colon, two from lung carcinoma) underwent ILP under US guidance. Depending on tumor size up to four needles were inserted in the tumor and multiple laser illuminations were performed in one or multiple sessions. Necrosis of the nodules was evaluated with triphasic contrast-enhanced CT.
RESULTS: Ninety-four patients underwent a single ILP session and nine patients two sessions. CT showed complete necrosis in 70 out of 85 HCC nodules in 65 treated patients and in 24 out of 31 patients with metastases. Three Child C class patients dropped out the control of efficacy by CT because of severe liver failure associated in one case with transient paralytic ileum. One of these patients died 2 months after treatment. Two patients with metastasis dropped the completion of the treatment because of complication occurred after the ILP session (one paralytic ileum, one gastric haemorrage).
CONCLUSIONS: ILP under US guidance is effective in inducing complete necrosis in small and large liver tumors. Nevertheless, ILP can cause severe derangement of liver function in patients with advanced cirrhosis.

Entities:  

Mesh:

Year:  2000        PMID: 10874193     DOI: 10.1016/s0929-8266(00)00086-0

Source DB:  PubMed          Journal:  Eur J Ultrasound        ISSN: 0929-8266


  7 in total

Review 1.  Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives.

Authors:  Giovan Giuseppe Di Costanzo; Giampiero Francica; Claudio Maurizio Pacella
Journal:  World J Hepatol       Date:  2014-10-27

Review 2.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

3.  Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.

Authors:  D Dimitroulopoulos; D Xinopoulos; K Tsamakidis; A Zisimopoulos; E Andriotis; D Panagiotakos; A Fotopoulou; C Chrysohoou; A Bazinis; D Daskalopoulou; E Paraskevas
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

4.  [Current concepts and recent developments of laser ablation in tumor therapy].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; R Puls; N Hosten; U Speck; J Ricke; H Oettle; P Hohenberger; R Felix
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

5.  Laser ablation for small hepatocellular carcinoma.

Authors:  Claudio Maurizio Pacella; Giampiero Francica; Giovanni Giuseppe Di Costanzo
Journal:  Radiol Res Pract       Date:  2011-12-04

Review 6.  Local ablative treatments for hepatocellular carcinoma: An updated review.

Authors:  Antonio Facciorusso; Gaetano Serviddio; Nicola Muscatiello
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

7.  Innovative approaches for cancer treatment: current perspectives and new challenges.

Authors:  Carlotta Pucci; Chiara Martinelli; Gianni Ciofani
Journal:  Ecancermedicalscience       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.